GRI
Cohen & Steers Global Realty Majors ETF [GRI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GRI Stock Summary
Top 10 Correlated ETFs
GRI
Top 10 Correlated Stocks
GRI
In the News
GRI Financial details
Company Rating
Sell
Market Cap
1.63M
Income
-13.33M
Revenue
5.39M
Book val./share
0.4
Cash/share
2.8
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.11
Forward P/E
-
PEG
0.01
P/S
-
P/B
0.65
P/C
0.18
P/FCF
-0.37
Quick Ratio
1.6
Current Ratio
2.01
Debt / Equity
0.05
LT Debt / Equity
-
-
-
EPS (TTM)
-64.31
EPS next Y
-
EPS next Q
-
EPS this Y
-96.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-14.6%
-
-
-
-
SMA20
-33.75%
SMA50
-72.25%
SMA100
-93%
Inst Own
-
Inst Trans
-
ROA
-309%
ROE
-1164%
ROC
-5.56%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.503-115.5
52W High
-
52W Low
-
RSI
28.03
Rel Volume
0.08
Avg Volume
763.61K
Volume
58.37K
Perf Week
-6.56%
Perf Month
-37.04%
Perf Quarter
-93.32%
Perf Half Y
-95.11%
-
-
-
-
Beta
-1.7959
-
-
Volatility
0.02%, 0.13%
Prev Close
-2.54%
Price
0.51
Change
-9.01%
GRI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 3.08 | 0 | 0 | 0 | |
| Net income per share | -106.82 | -148.68 | -46.51 | -823.76 | -28.25 | |
| Operating cash flow per share | -88.91 | -114.27 | -26.11 | -252.34 | -19.8 | |
| Free cash flow per share | -88.91 | -114.33 | -26.11 | -253.03 | -19.82 | |
| Cash per share | 117.81 | 3.36 | 120.15 | 2.09 | 3.92 | |
| Book value per share | 99.09 | -44.83 | -145.61 | -377.92 | 0.56 | |
| Tangible book value per share | 99.09 | -44.83 | -145.61 | -377.92 | 0.56 | |
| Share holders equity per share | 99.09 | -44.83 | -145.61 | -377.92 | 0.56 | |
| Interest debt per share | 8.72 | 6.17 | 128.26 | 308.39 | 4.54 | |
| Market cap | 1.57M | 51.22M | 40.74M | 261.86K | 1.24M | |
| Enterprise value | -1.91M | 51.45M | 44.26M | 925.86K | -552.39K | |
| P/E ratio | -0.45 | -10.62 | -27 | -0.07 | -0.1 | |
| Price to sales ratio | 0 | 512.18 | 0 | 0 | 0 | |
| POCF ratio | -0.54 | -13.82 | -48.1 | -0.24 | -0.14 | |
| PFCF ratio | -0.54 | -13.81 | -48.1 | -0.24 | -0.14 | |
| P/B Ratio | 0.49 | -35.23 | -8.62 | -0.16 | 4.79 | |
| PTB ratio | 0.49 | -35.23 | -8.62 | -0.16 | 4.79 | |
| EV to sales | 0 | 514.45 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0.61 | -10.92 | -43.7 | -0.42 | 0.05 | |
| EV to operating cash flow | 0.66 | -13.88 | -52.26 | -0.85 | 0.06 | |
| EV to free cash flow | 0.66 | -13.87 | -52.26 | -0.85 | 0.06 | |
| Earnings yield | -2.21 | -0.09 | -0.04 | -13.53 | -10.5 | |
| Free cash flow yield | -1.84 | -0.07 | -0.02 | -4.15 | -7.37 | |
| Debt to equity | 0.03 | -0.11 | -0.77 | -0.41 | 0.05 | |
| Debt to assets | 0.02 | 0.17 | 16.58 | 1.76 | 0 | |
| Net debt to EBITDA | 1.1 | -0.05 | -3.48 | -0.3 | 0.16 | |
| Current ratio | 4.86 | 0.3 | 0.02 | 0.15 | 1.09 | |
| Interest coverage | -16.01 | -140.82 | -1.94 | -3.43 | -5.47 | |
| Income quality | 0.83 | 0.77 | 0.54 | 0.34 | 0.7 | |
| Dividend Yield | 0 | 0 | 0 | 13.16 | 0 | |
| Payout ratio | 0 | 0 | 0 | -0.97 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 37.07 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | -0.02 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | -0.03 | 0 | -0.06 | -0.14 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 488.02 | 387.26 | 390.38 | 2.65K | 18.88 | |
| ROIC | -0.89 | 4.28 | 1.03 | 2.8 | -39.68 | |
| Return on tangible assets | -0.81 | -5.05 | -6.92 | -9.25 | -4.41 | |
| Graham Net | 85.07 | -70.92 | -32.18 | -464.9 | -1.93 | |
| Working capital | 3.11M | -1.55M | -4.78M | -1.69M | 237K | |
| Tangible asset value | 3.21M | -1.45M | -4.72M | -1.63M | 259K | |
| Net current asset value | 2.86M | -1.74M | -4.85M | -1.7M | 237K | |
| Invested capital | 0.03 | -0.11 | -0.77 | -0.41 | 0.05 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 736.16K | 641.5K | 675.5K | 1.35M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 122.33K | 0 | 285 | 2.29K | 9.03K | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 1.28 | 0.16 | 0.04 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | -1.08 | 3.32 | 0.32 | 2.18 | -50.34 | |
| Capex per share | 0 | -0.06 | 0 | -0.7 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2024-01-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2024-01-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 8.35 | |
| Net income per share | -35.34 | -38.05 | -19.53 | -3.63 | -3.1 | |
| Operating cash flow per share | -13.15 | -32.96 | -0.01 | -2.23 | -8.61 | |
| Free cash flow per share | -13.19 | -32.96 | -0.03 | -2.23 | -8.61 | |
| Cash per share | 0.14 | 25.93 | 13.89 | 5.92 | 2.8 | |
| Book value per share | -25.31 | 0.48 | 11.69 | 3.78 | 0.4 | |
| Tangible book value per share | -25.31 | 0.48 | 11.69 | 3.78 | 0.4 | |
| Share holders equity per share | -25.31 | 0.48 | 11.69 | 3.78 | 0.4 | |
| Interest debt per share | 10.48 | 0.73 | 2.82 | 0.05 | 0.02 | |
| Market cap | 3.91M | 4.88M | 10.28M | 6.39M | 1.05M | |
| Enterprise value | 4.57M | 3.21M | 5.52M | 2.93M | -747.9K | |
| P/E ratio | -0.43 | -0.5 | -0.38 | -0.75 | -0.13 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0.19 | |
| POCF ratio | -4.63 | -2.3 | -3.43K | -4.88 | -0.19 | |
| PFCF ratio | -4.62 | -2.3 | -934.14 | -4.88 | -0.19 | |
| P/B Ratio | -2.41 | 157.27 | 2.54 | 2.87 | 4.04 | |
| PTB ratio | -2.41 | 157.27 | 2.54 | 2.87 | 4.04 | |
| EV to sales | 0 | 0 | 0 | 0 | -0.14 | |
| Enterprise value over EBITDA | -2.35 | -1.4 | -0.93 | -1.18 | 0.37 | |
| EV to operating cash flow | -5.42 | -1.52 | -1.84K | -2.24 | 0.13 | |
| EV to free cash flow | -5.4 | -1.52 | -501.6 | -2.24 | 0.13 | |
| Earnings yield | -0.58 | -0.5 | -0.66 | -0.33 | -1.92 | |
| Free cash flow yield | -0.22 | -0.43 | 0 | -0.21 | -5.32 | |
| Debt to equity | -0.41 | 0 | 0.01 | 0.01 | 0.05 | |
| Debt to assets | 1.76 | 0 | 0.01 | 0.01 | 0 | |
| Net debt to EBITDA | -0.34 | 0.73 | 0.8 | 1.39 | 0.89 | |
| Current ratio | 0.15 | 1.02 | 3.49 | 2.01 | 1.09 | |
| Interest coverage | 0 | -49.98 | -6.35 | 0 | 0 | |
| Income quality | 0.37 | 0.88 | 0 | 0.61 | 2.77 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.18 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0.19 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 2.67 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | -0.06 | 0 | -4 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.01 | |
| Graham number | 141.87 | 20.33 | 71.68 | 17.56 | 5.29 | |
| ROIC | 1.62 | -77.26 | -1.64 | -1.04 | -12.72 | |
| Return on tangible assets | -5.92 | -1.16 | -1.2 | -0.49 | -0.68 | |
| Graham Net | -31.14 | -6.25 | 9.25 | 2.23 | -1.38 | |
| Working capital | -1.69M | 31K | 3.99M | 2.19M | 237K | |
| Tangible asset value | -1.63M | 31K | 4.04M | 2.23M | 259K | |
| Net current asset value | -1.7M | 31K | 3.99M | 2.19M | 237K | |
| Invested capital | -0.41 | 0 | 0.01 | 0.01 | 0.05 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 1.24M | 911K | 417.5K | 647.5K | 1.2M | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 13.82K | 88.92K | 8.46K | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0.01 | 0 | 0.01 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 1.4 | -78.81 | -1.67 | -0.96 | -7.74 | |
| Capex per share | -0.05 | 0 | -0.02 | 0 | 0 |
GRI Frequently Asked Questions
What is Cohen & Steers Global Realty Majors ETF stock symbol ?
Cohen & Steers Global Realty Majors ETF is a US stock , located in La jolla of Ca and trading under the symbol GRI
What is Cohen & Steers Global Realty Majors ETF stock quote today ?
Cohen & Steers Global Realty Majors ETF stock price is $0.51 today.
Is Cohen & Steers Global Realty Majors ETF stock public?
Yes, Cohen & Steers Global Realty Majors ETF is a publicly traded company.
Company Profile
- Volume Average 763.61K
- Market Capitalization 1.63M
- Employee 4
- CEO Dr. W. Marc Hertz Ph.D.
- Headquarters LA Jolla,CA,US
- IPO Date 2021-02-10
-
Website
https://www.gribio.com 
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
